SCHEMBL31696260

SCHEMBL31696260

N=C(N)NCCC[C@@H](NC(=O)[C@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCC(N)=O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GRB2 P62993 1/20 0.44
▸ MAPK8 P45983 1/20 0.43
▸ MAPK9 P45984 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ KDM1A O60341 3/20 0.43
▸ MAOB P27338 1/20 0.39
▸ KDM5A P29375 1/20 0.39
▸ KDM1B Q8NB78 1/20 0.39
▸ NMUR2 Q9GZQ4 3/20 0.39
▸ NMUR1 Q9HB89 3/20 0.39
▸ OPRK1 P41145 5/20 0.38
▸ OPRM1 P35372 4/20 0.38
▸ OPRD1 P41143 4/20 0.38
▸ NPFFR2 Q9Y5X5 4/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ NRP1 O14786 1/20 0.38
▸ REN P00797 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7163251 0.91 MAPK8 (0.40) GRB2MAPK8MAPK9MAPK10KDM1A
SCHEMBL7163247 0.91 MAPK8 (0.40) GRB2MAPK8MAPK9MAPK10KDM1A
SCHEMBL3215690 0.91 MAPK8 (0.51) GRB2MAPK8MAPK9MAPK10KDM1A
SCHEMBL28758609 0.91 REN (0.44) GRB2MAPK8MAPK9MAPK10KDM1A
SCHEMBL29630697 0.89 GRB2 (0.44) GRB2OPRK1OPRM1OPRD1NPFFR2
SCHEMBL29591671 0.89 GRB2 (0.44) GRB2OPRK1OPRM1OPRD1NPFFR2
SCHEMBL30658576 0.89 KDM1A (0.51) MAPK8MAPK9MAPK10KDM1AMAOB
SCHEMBL7899891 0.88 GRB2 (0.41) GRB2OPRK1
SCHEMBL7899895 0.88 GRB2 (0.41) GRB2OPRK1
SCHEMBL31696335 0.87 KDM1A (0.54) MAPK8MAPK9MAPK10KDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250312463-A1 AUGMENTED PEPTIDE COMPOSITIONS AND METHODS Neo7Bioscience, Inc. (US) 2025-10-09 — — US disclosed
Send feedback